Overview
Work History
Skills
Accomplishments
Interests
Additional Information
Timeline
Generic

Your Name

BENZ, Ocala,AMY, FL

Overview

20
20
years of professional experience

Work History

01.2010 - Current
  • This is a 53 year old female who: is being seen for a chief complaint of chronic low back pain involving the spine
  • Context: having chronic back pain
  • They are constant
  • Quality: aching
  • Severity is 7 out of 10 currently
  • Is being seen for a chief complaint of follow up low back pain involving the spine
  • Symptoms are aggravated by all movement
  • They are constant
  • Quality: aching and sharp
  • Severity is 6 out of 10 currently
  • Since the last visit, the status of the problem is unchanged
  • Secondary Complaints include: The patient complains of thoracic spine pain
  • The symptoms are 7 out of, Date Taken By B.P
  • Pulse Resp
  • O2 Sat
  • Temp
  • Ht
  • Wt
  • BMI BSA

07.2026 - 01.2024
  • Patient presents today for follow-up regarding chronic axial mid back and lumbar spine pain
  • Patient recently trialed on duloxetine, side effect of persistent nausea minimal relief to 90 with medication
  • Patient request continued on this medication
  • Patient is also previously trialed gabapentin and pregabalin discontinued those due to significant side effects
  • Patient did have to reschedule her confirmatory bilateral T9/T10, T10/T11 thoracic medial branch block #2, this will be completed and was evaluated at her next office visit
  • Patient gets significant pain relief from this we will consider radiofrequency ablation at the same level
  • Patient currently takes hydrocodone 7.5 mg / 325 mg every 8 hours, as needed
  • Approximately 70 to 80% pain relief when taking hydrocodone denies significant side effects
  • UDS and PDMP are appropriate
  • Patient also has been contacted by Zynex, her e-stim for her back pain should be shipping soon
  • Today I have ordered a repeat thoracic and lumbar spine MRI due to patient's severe persistent spine pain.

Sex
Ocala, FL
01.2005 - 12 0
  • Quality 134 (Screening for Clinical Depression and Follow-Up Plan): The patient was screened for depression and the screen was negative and no follow up required
  • Additional Notes: PHQ2 depression screening administered, negative result found
  • Note:
  • Indra Ramdayal dnp
  • Visit Note - September 20, 2024
  • BENZ, AMY
  • MRN:
  • FPA561035
  • Phone: (352) 414-9837
  • DOB:, Female
  • PMS ID:
  • FPA561035
  • Page 7Indra Ramdayal, NP (Primary Provider) (Bill Under) (352) 629-7011 Work (866) 592-7773 Fax
  • PA Ocala 1910SW 18th Court, Indra Ramdayal, NP (Primary Provider) (Bill Under)
  • Kathy Hicks
  • Patient Referrals:
  • Lumapas, Neal - Primary Care Provider (PCP)
  • I have reviewed and agree with the findings of midlevel
  • MIPS:
  • Plan: MIPS Quality
  • MIPS:
  • Plan: MIPS Quality
  • Spondylosis, Lumbar:
  • Plan: Care timeline
  • Thoracic Spine Pain:
  • Plan: Prescription
  • Long term (current) use of opiate analgesic:
  • Plan: Morphine Milligram Equivalent, State Opioid Prescribing Database Reviewed, Counseling - Medication Monitoring, and Toxicology Review
  • High Risk Medication Monitoring Narcotics:
  • Plan: Toxicology Review
  • Electronically Signed By: Jason Wei, MD, 09/21/2024 04:41 PM EDT, ID:
  • FPA561035, FPA561035
  • Page 3Indra Ramdayal, NP (Primary Provider) (Bill Under) (352) 629-7011 Work (866) 592-7773 Fax
  • PA Ocala 1910SW 18th Court Suite #200
  • Ocala, FL 34471
  • Refill hydrocodone 7.5 mg 3 times daily as needed, FPA561035
  • Page 4Indra Ramdayal, NP (Primary Provider) (Bill Under) (352) 629-7011 Work (866) 592-7773 Fax
  • PA Ocala 1910SW 18th Court Suite #200, 34471
  • Right Hip: FABER test: negative and FADIR test: negative
  • Left Hip: FABER test: negative and FADIR test: negative
  • T-Spine ROM: grossly intact
  • L-Spine ROM: grossly limited and with pain
  • Extension: limited and with pain
  • Rotation to the right: limited and with pain
  • Rotation to the left: limited and with pain
  • Right Hip ROM:
  • Flexion: 150 degrees
  • Extension: 0 degrees
  • Abduction: 45 degrees
  • Adduction: 30 degrees
  • Internal Rotation: 45 degrees
  • External Rotation: 45 degrees
  • Left Hip ROM:
  • Flexion: 150 degrees
  • Extension: 0 degrees
  • Abduction: 45 degrees
  • Adduction: 30 degrees
  • Internal Rotation: 45 degrees
  • External Rotation: 45 degrees
  • Right Iliopsoas: Strength: 5/5, normal muscle tone
  • Left Iliopsoas: Strength: 5/5, normal muscle tone
  • Right Hip Abduction: Strength: 5/5, normal muscle tone
  • Left Hip Abduction: Strength: 5/5, normal muscle tone
  • Right Hip Adduction: Strength: 5/5, normal muscle tone
  • Left Hip Adduction: Strength: 5/5, normal muscle tone
  • Right Quadriceps: Strength: 5/5, normal muscle tone
  • Left Quadriceps: Strength: 5/5, normal muscle tone
  • Right Hamstring: Strength: 5/5, normal muscle tone
  • Left Hamstring: Strength: 5/5, normal muscle tone
  • Right EHL: Strength: 5/5, normal muscle tone
  • Left EHL: Strength: 5/5, normal muscle tone
  • Right Tibialis Anterior: Strength: 5/5, normal muscle tone
  • Left Tibialis Anterior: Strength: 5/5, normal muscle tone
  • Right Plantar Flexion: Strength: 5/5, normal muscle tone
  • Left Plantar Flexion: Strength: 5/5, normal muscle tone
  • Right Foot Eversion: Strength: 5/5, normal muscle tone
  • Left Foot Eversion: Strength: 5/5, normal muscle tone
  • Inversion: Strength: 5/5, normal muscle tone
  • Inversion: Strength: 5/5, normal muscle tone
  • RLE Dermatomal Sensation: normal to light touch throughout dermatomes
  • LLE Dermatomal Sensation: normal to light touch throughout dermatomes
  • RLE Peripheral Sensation: insensate to light touch throughout peripheral nerve distributions
  • LLE Peripheral Sensation: insensate to light touch throughout peripheral nerve distributions
  • RLE Reflexes: DTRs normal active LLE Reflexes: DTRs normal active
  • Visit Note - September 20, 2024
  • BENZ, AMY
  • MRN:
  • FPA561035
  • Phone: (352) 414-9837
  • DOB:, FPA561035
  • Page 5Indra Ramdayal, NP (Primary Provider) (Bill Under) (352) 629-7011 Work (866) 592-7773 Fax
  • PA Ocala 1910SW 18th Court Suite #200, 34471
  • Right LE Pulses: normal posterior tibialis and dorsal pedis pulses, brisk capillary refill, no edema
  • Left LE Pulses: normal posterior tibialis and dorsal pedis pulses, brisk capillary refill, no edema
  • Data Reviewed:Review of the result(s) of each unique test (Toxicology Review (no))
  • Impression/Plan:
  • Spondylosis, Lumbar
  • Problem Addressed: Stable chronic illness
  • Spondylosis without myelopathy or radiculopathy, lumbar region (M47.816)
  • Thoracic Spine Pain
  • Problem Addressed: Stable chronic illness
  • Pain in thoracic spine (M54.6)
  • Plan: Prescription
  • Hydrocodone 7.5 mg-acetaminophen 325 mg tablet PO
  • Sig: One po Q 8 hrs as needed for non acute pain
  • Quantity: 90 Tablet Earliest fill date: September 28, 2024 baclofen 10 mg tablet PO
  • Sig: One tablet q 12 hours as needed for muscle spasms
  • Quantity: 60 Tablet Earliest fill date: September 20, 2024
  • Valium 5 mg tablet PO
  • Sig: Bring tablet to procedure will be instructed on use
  • Quantity: 1 Tablet Earliest fill date: September 20, 2024
  • Long term (current) use of opiate analgesic
  • Problem Addressed: Stable chronic illness
  • Long term (current) use of opiate analgesic (Z79.891)
  • Plan: Morphine Milligram Equivalent
  • All conversion factors yield MILLIGRAM morphine equivalent
  • Hydrocodone (mg/day): 21
  • Morphine Milligram Equivalent per day: 21.00
  • Plan: State Opioid Prescribing Database Reviewed
  • The state database has been accessed and reviewed prior to prescribing a Class II and/or Class III controlled substance
  • Plan: Counseling - Medication Monitoring
  • Opioid Counseling
  • Medication Counseling Other : Risks associated with long term use of opioids: Given the patients diagnosis and persistent chronic pain
  • Treatment with opioid analgesic medication will likely be required for long term use
  • At this visit I discussed the possible development of adverse-affects from the long-term use of opioids including: the development of physical tolerance to the medication, development of hyperalgesia and/or development of physical addiction
  • I have further explained to the patient that any one adverse-affect may require either opioid rotation, tapering or discontinuation
  • Safe use of Controlled Substance medication: The patient was instructed to take their controlled substance medication only as directed
  • The patient was also advised not to consume any alcohol or illicit substances throughout the course of treatment with the controlled substance(s)
  • The patient was asked to review the type of medication and instructions for administration at time of prescription pick-up from the pharmacy to confirm correct medication and instructions have been given
  • The patient was also instructed on the potential side-affects that may occur with use of controlled substance(s) as well as signs of over medication
  • If the
  • Visit Note - September 20, 2024
  • BENZ, AMY
  • MRN:
  • FPA561035
  • Phone: (352) 414-9837
  • DOB:, Female
  • PMS ID:
  • FPA561035
  • Page 6Indra Ramdayal, NP (Primary Provider) (Bill Under) (352) 629-7011 Work (866) 592-7773 Fax
  • PA Ocala 1910SW 18th Court Suite #200
  • Ocala, 34471 patient were to develop any slurred speech, dizziness, confusion, excessive drowsiness, trouble breathing, skin pallor, or difficulty waking from sleep he/she was advised to discontinue use of the controlled substance medication and to call the office or visit the emergency room
  • Safe storage of Controlled Substance medication: The patient was instructed that all controlled substance medications should be stored in their original bottles inside a locked cabinet, lockbox or a location where others cannot easily access them.

09.2020
  • 2435
  • Hicks, Kathy 128/84
  • SIT69.0 in 250.0 lbs9 2.3
  • FiO2
  • Patient Reported
  • Care timeline
  • Management history log
  • Summary: patient is here for follow-up visit, patient has been seen by Dr
  • Shetty
  • Status post bilateral L4-L5 transforaminal ESI on February 20, 2024 with Dr
  • Wei, greater than 80% relief for radiating pain to the right side anterior rib cage
  • Her main complaint is of right side of thoracic spine MRI her main complaint is right side of thoracic spine
  • T9-T12, she has tried ice, heat, NSAIDs, she is currently on physical therapy
  • She is having radicular pain to right cage and right flank from right side of thoracic spine
  • Her pain level is 8 out of 10 and pain is intensifying
  • She is not able to stand or sit for longer than 5 minutes
  • 28/2024
  • Patient presents today for follow-up visit regarding her chronic axial mid back pain and her chronic low back pain
  • Patient longstanding patient with Dr
  • Shetty manage for her low back pain
  • She is status post several lumbar L4/L5, L5/S1 transforaminal epidurals with variations of those over the years with Dr
  • Shetty, patient reports transient relief with these injections with 1 injection lasting approximately 1 week
  • Patient's status post bilateral T9/T10, T10/T11 thoracic medial branch block #1 4/30/2024 patient reports significant swelling at the injection site after the procedure but reports 80% pain relief for duration of anesthetic
  • We will proceed with the additional trial injection if that is successful we will plan for RFA at these levels
  • Patient currently taking hydrocodone 7.5-325 milligrams, every 8 hours, for her chronic low back and mid back pain
  • Patient reports approximately 80% pain relief for the duration of the medication which allows her to increase her mobility and complete her ADLs
  • She has previous taken gabapentin, pregabalin, in the past, discontinued due to side effects
  • UDT consistent
  • PDMP reviewed and consistent
  • Patient has completed several rounds of physical therapy for her mid back pain, patient states that the physical therapy itself was marginal in benefit but the commercial grade e-stim machine that was used on her mid back did provide great relief for her chronic thoracic spine pain
  • Today I have ordered a Zynex estim device to be used for patient's chronic mid back pain in addition to the interventional procedures
  • Visit Note - September 20, 2024
  • BENZ, AMY
  • MRN:
  • FPA561035
  • Phone: (352) 414-9837
  • DOB:

08.2026
  • 24
  • S/p Bilateral Levels: T9-T10 and T10-T11 MBB #2, 8/6/24, reporting >80% pain relief x 24 hrs
  • Discussed to Schedule RFA T-spine with Dr
  • Wei
  • Completed lumbar and thoracic spine
  • Discussed findings with patient and plans for future intervention post MBB/RFA T-spine procedure
  • Current regimen helping tolerable pain relief
  • No adverse side effects
  • Previous UDS 7/26/2024 + hydrocodone consistent
  • PDMP consistent
  • Plan
  • Bilateral Levels: T9-T10 and T10-T1 RFA
  • Refill med
  • Follow-up in 1 month20/2024
  • Schedule rfa
  • Order diazepam 5 mg x1
  • Patient has myofascial pain and swelling
  • Plan Due to multi level pain thoracic radiation
  • Order consult with Dr
  • Freeman Review multiple imaging Pdmp 8/29/2024 hydrocodone 7.5/325 #90 Udt 8/6/2024 hydrocodone and metabolitesbaclofen 10 mg q12 hours as needed.otc medications
  • Procedures/surgery:

Adjunct

01.2012
  • Right Tri mall fracture with ORIF
  • Previous management: previous therapies:, events: Gabapentin, pregabalin–stopped both due to side effects, Topamax–discontinued due to severe side effects
  • NSAIDs: Previous treatment with meloxicam, meloxicam, Voltaren, Aleve, naproxen–patient reports feeding therapy with these medications
  • Muscle relaxants: Flexeril, tizanidine, baclofen–fleeting response with these medications
  • Other:
  • Plan
  • Meds:
  • Visit Note - September 20, 2024
  • BENZ, AMY
  • MRN:
  • FPA561035
  • Phone: (352) 414-9837
  • DOB:

Skills

  • Mcg/actuation Nasal -
  • Spray,suspension
  • Amlodipine 5 mg Oral - tablet
  • Celecoxib 200 mg Oral - capsule
  • Cyclobenzaprine 10 mg Oral -
  • Tablet
  • Duloxetine 20 mg Oral - Dose: 1
  • Capsule capsule,delayed
  • Release (ec) Frequency: Once
  • A day
  • Hydrocodone-acetaminophen
  • 75-325 mg Oral - tablet
  • Hydroxyzine HCl 10 mg Oral -
  • Losartan 25 mg Oral - tablet
  • Meloxicam 15 mg Oral - tablet
  • Rosuvastatin 10 mg Oral - tablet
  • Tizanidine 2 mg Oral - tablet
  • Medical History
  • Reviewed August 26, 2024
  • Chronic pain
  • Fatigue
  • Gastroesophageal reflux
  • Disease
  • H/O: depression
  • H/O: varicose veins
  • Headache: Migraines
  • Hernia: hiatal
  • History of urinary tract infection
  • Hypercholesterolemia
  • Insomnia
  • Obesity
  • Sleep apnea
  • Other: High Blood Pressure
  • Urinary Incontinence
  • Interventional Pain
  • Musculoskeletal
  • History
  • Chronic low back pain
  • Fracture of ankle
  • H/O: arthritis
  • Neuropathy
  • Sciatica
  • Spinal stenosis of lumbar region
  • Family History
  • Diabetes
  • Hypertension
  • Osteoarthritis
  • Osteoporosis
  • Scoliosis
  • Chief Complaints:
  • Chronic Low Back Pain1
  • Follow Up Low Back Pain2

Accomplishments

  • T spine and L spine MRI
  • Procedure: Bilateral T9/T10, T10/T11 thoracic medial branch block #2 with Dr
  • Wei
  • If successful we will consider RFA at these levels
  • HEP: yes lumbar
  • RTC: 4 weeks
  • Findings:
  • General Appearance
  • Appearance: overweight, well developed, and well groomed
  • Orientation: Alert and oriented to person, place, time
  • Mood: mood and affect well-adjusted, pleasant and cooperative, appropriate for clinical and encounter circumstances
  • T-spine
  • T-Spine ROM: Moderate to severe tenderness midline and Right > Left PV area of the mid thoracic spine
  • T-Spine Inspection: kyphoscoliosis, left paraspinal musculature tender to palpation, right paraspinal musculature tender to palpation, and midline tenderness
  • TL-Spine and Hip
  • Gait: mildly antalgic
  • Upper Trunk Skin Inspection: skin intact, no rashes or lesions
  • Lower Trunk Skin Inspection: skin intact, no rashes or lesions
  • T-Spine Inspection: no paraspinal musculature tenderness and no scoliosis
  • L-Spine Inspection: left and right paraspinal musculature tender to palpation
  • Posture: lumbar hypolordosis: mild
  • Inspection:
  • Right Hip: no trochanteric tenderness
  • Inspection:
  • Left Hip: no trochanteric tenderness
  • L-Spine Stability: No bony step-off, no gross deformity, normal sagittal and coronal alignment
  • Thoracolumbar Spine Special: FABER test: negative on the left, FABER test: negative on the right
  • Facet Loading test: positive to the left, Facet Loading test: positive to the right, Facet Loading test: positive to extension, Right SLR ipsilateral pain: negative, Left SLR ipsilateral pain: negative, and
  • Waddell's test: negative
  • Special: Special:
  • Visit Note - September 20, 2024
  • BENZ, AMY
  • MRN:
  • FPA561035
  • Phone: (352) 414-9837, REASON > 72 HOUR RX GIVEN: Based on the patient’s chronic non-malignant pain, a prescription for greater than a 72-hour supply of opioid analgesic medication is being prescribed today
  • The patient will require chronic long-term treatment with an opioid analgesic to facilitate a reduction in the patient’s pain level as well as to maintain adequate physical function
  • PDMP reviewed at this visit
  • At this visit we discussed and reviewed the non-opioid and non-narcotic alternatives including but not limited to physical therapy, interventional pain procedures, and NSAIDS, if appropriate
  • The patient was provided with the information on Nonopioid Alternative for the Treatment of Pain Pamphlet
  • Plan: Toxicology Review
  • Specimen Type: Urine
  • The following confirmation positive results were found: Hydrocodone and Norhydrocodone
  • Patient Specific Counseling: REV OF UDT 7/24/2024 hydrocodne and metabolites AND PDMP SHOWS COMPLIANCE
  • Patient Specific Counseling: -
  • High Risk Medication Monitoring Narcotics
  • Problem Addressed: No MDM
  • Long term (current) use of opiate analgesic (Z79.891)
  • Associated diagnosis: Encounter for therapeutic drug level monitoring (No MDM)
  • Plan: Toxicology Review
  • The state database has been accessed and reviewed prior to prescribing a Class II and/or Class III controlled substance
  • Urine drug screening is being ordered today to assess compliance with prescribed medications and identify common prescribed and non-prescribed substances that can impact medical efficacy and patient safety
  • Based on the reason(s) indicated in the completed scanned in lab requisition form, a Definitive Test will also be ordered
  • Date of Toxicology Testing: 07/26/2024
  • Specimen Type: Urine
  • Patient Specific Counseling: -
  • The following POC positive results were found: Opiates/Morphine
  • The following POC negative results were found: Amphetamines, Cocaine, Marijuana, and Methamphetamine
  • The following POC normal results were found: Bleach, Creatinine, Nitrate, pH, and Specific Gravity
  • MIPS
  • MIPS
  • Plan: MIPS Quality
  • Quality 317 (Preventative Care and Screening: Screening for High Blood Pressure and Follow-up Documented): Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented
  • Additional Notes: The patient is referred to their PCP and educated regarding hypertension
  • MIPS
  • Plan: MIPS Quality.

Interests

DOB: , 05/19/1971 Sex: Female, Driving status: , Drives in the Daytime Drives at Night

Additional Information

  • PMS ID: , FPA561035

Timeline

08.2026

07.2026 - 01.2024

09.2020

Adjunct

01.2012

01.2010 - Current

Sex
01.2005 - 12 0